+91 95123 08383

Support 24/7

0Your Cart₹ 0.00

Cart (0)

No products in the cart.

Calbiotech CA15-3 ELISA

₹ 0.00 ₹ 0.00

The Calbiotech CA15-3 ELISA Kit is intended for the quantitative determination of the cancer antigen CA15-3 concentration in human serum or plasma.

Product Insert

In stock

Test Principle:

Species:

Assay Type:

Pack Size:

SKU:CA240T
Free Technical Support
Free Technical Support
Free Comprehensive Technical Support
Extensive Product Portfolio
Extensive Product Portfolio
Extensive range of critical & advanced research testing kits
Across Categories
Across Categories
Human, Veterinary, Food Safety, Research & Animal
Hotline Order:

Mon - Sat: 10AM - 06PM

(+91) 95123 08383

Become a Vendor?Register now

SUMMARY AND EXPLANATION 
Breast cancer is the most common life-threatening malignant lesion in women of developed countries today, with approximately 180,000 new cases diagnosed every year. Roughly half of these newly diagnosed patients are node-negative, however 30% of these cases progress to metastatic disease. There are a number of tumor markers that can help clinicians to identify and diagnose which breast cancer patients will have a more aggressive disease. These markers include estrogen and progesterone receptors, DNA ploidy and percent-S phase profile, epidermal growth factor receptor, HER-2/neu oncogene, p53 tumor suppressor gene, cathepsin D, proliferation markers and CA15-3. CA15-3 is most useful for monitoring patients post-operatively for recurrence, particularly in metastatic disease cases. 96% of patients with local and systemic recurrence have elevated CA15-3, which can be used to predict recurrence earlier than radiological and clinical criteria. A 25% increase in the serum CA15-3 is associated with progression of carcinoma. A 50% decrease in serum CA15-3 is associated with response to treatment. CA15-3 is more sensitive than CEA in early detection of breast cancer recurrence. In combination with CA125, CA15-3 has been shown to be useful in early detection of relapse of ovarian cancer. CA15-3 levels are also increased in colon, lung and hepatic tumors.

PRINCIPLE OF THE TEST 
The CA15-3 ELISA test is an adapted solid phase sequential sandwich ELISA. Samples and biotinylated monoclonal antibody are added to wells coated with streptavidin. CA15-3 in the patient sample binds to biotinylated capture antibody. The biotinylated antibody simultaneously binds to the streptavidin coated plate. After a wash step, anti-CA15-3–HRP enzyme conjugate is added and forms a sandwich around captured CA15-3. Unbound antibodies are washed off. TMB substrate is added resulting in the development of a blue color. The concentration of CA15-3 is directly proportional to the color intensity developed. A standard curve is generated relating color intensity to CA15-3 concentration.

STORAGE AND STABILITY 
1. Store the kit at 2-8°C. 
2. Keep microwells sealed in a dry bag with desicants. 
3. The reagents are stable until expiration of the kit. 
4. Do not expose test reagents to heat, sun or strong light

Add your review

Your email address will not be published. Required fields are marked *

Please login to write review!

Upload photos

Looks like there are no reviews yet.

Related products